BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33851708)

  • 21. DNA methylation signatures associated with prognosis of gastric cancer.
    Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
    BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
    Zhang X; Jiang Y; Xie Y; Leng X; Song F
    DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer.
    Chen YY; Li BP; Wang JF; Wang Y; Luo SS; Lin RJ; Liao XW; Chen JQ
    BMC Cancer; 2023 Nov; 23(1):1122. PubMed ID: 37978366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of Overall Survival in Gastric Cancer Using a Nine-lncRNA.
    Cai C; Yang L; Tang Y; Wang H; He Y; Jiang H; Zhou K
    DNA Cell Biol; 2019 Sep; 38(9):1005-1012. PubMed ID: 31335180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and Validation of the Immune Regulator CXCR4 as a Novel Promising Target for Gastric Cancer.
    Xue S; Ma M; Bei S; Li F; Wu C; Li H; Hu Y; Zhang X; Qian Y; Qin Z; Jiang J; Feng L
    Front Immunol; 2021; 12():702615. PubMed ID: 34322132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
    Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
    PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
    Pan HX; Bai HS; Guo Y; Cheng ZY
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of ADAMTS-2 in tumor cells and stroma is predictive of poor clinical prognosis in gastric cancer.
    Jiang C; Zhou Y; Huang Y; Wang Y; Wang W; Kuai X
    Hum Pathol; 2019 Feb; 84():44-51. PubMed ID: 30218755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADAMTS Gene-Derived circRNA Molecules in Non-Small-Cell Lung Cancer: Expression Profiling, Clinical Correlations and Survival Analysis.
    Pietrzak J; Świechowski R; Wosiak A; Wcisło S; Balcerczak E
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339175
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Wang G; Sun D; Li W; Xin Y
    Biomed Res Int; 2020; 2020():6726759. PubMed ID: 32462010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
    Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
    Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
    [No Abstract]   [Full Text] [Related]  

  • 35. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
    Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
    Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical correlations and prognostic value of Nudix hydroxylase 10 in patients with gastric cancer.
    Chen D; Zhang R; Xie A; Yuan J; Zhang J; Huang Y; Zhang H; Zhang F
    Bioengineered; 2021 Dec; 12(2):9779-9789. PubMed ID: 34696672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
    Zhao E; Zhou C; Chen S
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101455. PubMed ID: 32505732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in Gastric Cancer.
    Zhao X; Zou J; Wang Z; Li G; Lei Y
    Biomed Res Int; 2021; 2021():9656947. PubMed ID: 33791386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.